Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
11/02/2025 | 03:06 | Edgar (US Regulatory) | Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] | AMEX:DSS | DSS Inc |
11/02/2025 | 00:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:DSS | DSS Inc |
06/02/2025 | 23:09 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:DSS | DSS Inc |
03/02/2025 | 14:50 | GlobeNewswire Inc. | DSS, Inc. Issues Letter to Shareholders | AMEX:DSS | DSS Inc |
13/12/2024 | 03:56 | Edgar (US Regulatory) | Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] | AMEX:DSS | DSS Inc |
13/11/2024 | 23:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:DSS | DSS Inc |
06/11/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:DSS | DSS Inc |
31/10/2024 | 22:08 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of 1933: [Amend] | AMEX:DSS | DSS Inc |
22/10/2024 | 23:25 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | AMEX:DSS | DSS Inc |
22/10/2024 | 23:20 | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | AMEX:DSS | DSS Inc |
19/09/2024 | 02:52 | Edgar (US Regulatory) | Form 3/A - Initial statement of beneficial ownership of securities: [Amend] | AMEX:DSS | DSS Inc |
17/09/2024 | 12:16 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | AMEX:DSS | DSS Inc |
16/09/2024 | 22:26 | GlobeNewswire Inc. | DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value | AMEX:DSS | DSS Inc |
12/09/2024 | 23:18 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | AMEX:DSS | DSS Inc |
10/09/2024 | 15:00 | GlobeNewswire Inc. | AmericaFirst Funds Trust Announces Changes to Board of Trustees | AMEX:DSS | DSS Inc |
06/09/2024 | 22:06 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | AMEX:DSS | DSS Inc |
26/08/2024 | 22:08 | GlobeNewswire Inc. | DSS, Inc. Names Jason Grady as Interim Chief Executive Officer | AMEX:DSS | DSS Inc |
30/01/2024 | 14:05 | GlobeNewswire Inc. | Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." | AMEX:DSS | DSS Inc |
04/01/2024 | 14:15 | GlobeNewswire Inc. | DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market | AMEX:DSS | DSS Inc |
22/12/2023 | 22:30 | GlobeNewswire Inc. | DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan | AMEX:DSS | DSS Inc |
13/12/2023 | 22:15 | Edgar (US Regulatory) | Form DEF 14C - Other definitive information statements | AMEX:DSS | DSS Inc |
01/12/2023 | 22:15 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements | AMEX:DSS | DSS Inc |
28/11/2023 | 14:10 | GlobeNewswire Inc. | Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years | AMEX:DSS | DSS Inc |
14/11/2023 | 14:00 | GlobeNewswire Inc. | DSS Inc. Wins Patent Dispute with Nichia Corporation | AMEX:DSS | DSS Inc |
08/11/2023 | 14:31 | GlobeNewswire Inc. | DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock | AMEX:DSS | DSS Inc |
26/10/2023 | 23:25 | GlobeNewswire Inc. | DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule | AMEX:DSS | DSS Inc |
23/10/2023 | 14:25 | GlobeNewswire Inc. | DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical | AMEX:DSS | DSS Inc |
12/10/2023 | 14:25 | GlobeNewswire Inc. | DSS Inc. Issues Letter to Shareholders | AMEX:DSS | DSS Inc |
06/09/2023 | 14:40 | GlobeNewswire Inc. | DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary | AMEX:DSS | DSS Inc |
31/07/2023 | 14:15 | GlobeNewswire Inc. | DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. | AMEX:DSS | DSS Inc |